Frontiers in Immunology (Jan 2024)

Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study

  • Wen-Jie Wu,
  • Wen-Jie Wu,
  • Wen-Jie Wu,
  • Qian Liu,
  • Qian Liu,
  • Qian Liu,
  • Pu-Gen An,
  • Pu-Gen An,
  • Pu-Gen An,
  • Lin Wang,
  • Lin Wang,
  • Lin Wang,
  • Jian-Yun Zhang,
  • Jian-Yun Zhang,
  • Jian-Yun Zhang,
  • Yan Chen,
  • Yan Chen,
  • Yan Chen,
  • Tong Zhang,
  • Jie Zhang,
  • Jie Zhang,
  • Jie Zhang

DOI
https://doi.org/10.3389/fimmu.2023.1346845
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords